Charming Medical Limited Class A Ordinary Shares
NASDAQ:MCTAMedical - Care Facilities
+$0.00 today
- Market cap
- $445.55M
- Beta
- 0.00
- P/E (TTM)
- 414.6
- EPS (TTM)
- $0.07
Volume 0.00M
Average 0.87M
Fair Value & DCF
Compare our fair value with your own assumptions
Intrinsic Alpha selects a valuation method suited to the business. Use the calculator below to build an independent scenario with your preferred cash-flow basis.
Charming Medical Limited Class A Ordinary Shares
NASDAQ:MCTA
Intrinsic Alpha fair value
Locked
Current Price
$29.36
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Build your own valuation
Test an independent scenario and compare it with Intrinsic Alpha's estimate.
Sign in to use the DCF calculator
Free accounts get 5 valuations per week. Upgrade for more.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A — |
| Revenue | N/A | N/A | N/A | N/A — |
| Net Income | N/A | N/A | N/A | N/A — |
| EBIT | N/A | N/A | N/A | N/A — |
Analysis
Analysis will appear once historical growth or forward estimates are available for this company.
Estimates & History
Historical data and analyst estimates. Solid bars are actuals; dashed-border bars are future estimates.
Competitor Valuations
Peer stocks ranked by intrinsic value status
| Company | Market Cap | Price | Valuation | P/E | 1Y Return |
|---|---|---|---|---|---|
Agilon Health, Inc. NYSE:AGL | $1.51B | $89.71 | Not rated | -4.8 | +605.06% |
Annexon, Inc. NASDAQ:ANNX | $614.41M | $3.75 | Not rated | -4.8 | -13.30% |
Tactile Systems Technology, Inc. NASDAQ:TCMD | $535.50M | $23.64 | Overvalued | 29.1 | +9.04% |
The Oncology Institute, Inc. NASDAQ:TOI | $512.91M | $5.13 | Not rated | -121.1 | +56.88% |
Delcath Systems, Inc. NASDAQ:DCTH | $500.36M | $14.42 | Undervalued | 751.4 | +131.49% |
Cross Country Healthcare, Inc. NASDAQ:CCRN | $428.06M | $13.25 | Undervalued | -4.2 | +14.82% |
Simulations Plus, Inc. NASDAQ:SLP | $374.16M | $18.50 | Undervalued | -5.9 | +13.36% |
RxSight, Inc. NASDAQ:RXST | $208.80M | $5.02 | Not rated | -4.1 | -47.26% |
Nakamoto Inc. NASDAQ:NAKA | $131.71M | $7.36 | Undervalued | -0.2 | -79.27% |
Continue the stock analysis
Jump to another research area for this company.